Rchr
J-GLOBAL ID:200901075467588050   Update date: Oct. 24, 2024

Murakumo Yoshiki

ムラクモ ヨシキ | Murakumo Yoshiki
Affiliation and department:
Job title: 教授
Research field  (2): Experimental pathology ,  Molecular biology
Research keywords  (6): 分子生物学・発癌・DNA修復・突然変異・細胞周期調節 ,  cell cycle control ,  mutagenesis ,  DNA repair ,  carcinogenesis ,  molecular biology
Research theme for competitive and other funds  (27):
  • 2023 - 2026 胸腺腫発症ラットの原因遺伝子変異導入マウスを用いたヒトB型胸腺腫の病態解明
  • 2021 - 2024 DNA損傷トレランスタンパク質REV7を介した紫外線誘発皮膚癌の発生機序の解明
  • 2021 - 2024 術前化学療法進行胃癌に対する治療効果とDNA修復関連蛋白REV7の発現との関連
  • 2020 - 2023 Biomarkers for predicting response to immune checkpoint inhibitor therapy in malignant melanoma.
  • 2018 - 2021 Elucidation of novel molecular mechanisms for maintenance of spermatogonial stem cells and gametogenesis in the testis
Show all
Papers (145):
  • Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Masayoshi Tadehara, Taro Kogami, Masahiro Matsushita, Akiyoshi Hoshino, Itaru Sanoyama, et al. REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer science. 2024. 115. 2. 660-671
  • Kazu Shiomi, Masaaki Ichinoe, Ai Ushiwata, Koji Eshima, Ryo Nagashio, Shoko Hayashi, Dai Sonoda, Yasuto Kondo, Raito Maruyama, Masashi Mikubo, et al. Insight into the significance of CD8+ tumor-infiltrating lymphocytes in squamous cell lung cancer. Thoracic Cancer. 2023
  • Yuko Shimada, Takuya Kato, Yasutaka Sakurai, Hitoe Watanabe, Mayu Nonaka, Natsumi Nanaura, Masaaki Ichinoe, Yoshiki Murakumo. Identification of the promoter region regulating the transcription of the REV7 gene. Biochemical and biophysical research communications. 2023. 662. 8-17
  • Yoshiki Murakumo, Yasutaka Sakurai, Takuya Kato, Hiroshi Hashimoto, Masaaki Ichinoe. REV7 in Cancer Biology and Management. Cancers. 2023. 15. 6
  • Shotaro Tatekawa, Keisuke Tamari, Ryota Chijimatsu, Masamitsu Konno, Daisuke Motooka, Suguru Mitsufuji, Hirofumi Akita, Shogo Kobayashi, Yoshiki Murakumo, Yuichiro Doki, et al. N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma. Scientific Reports. 2022. 12. 1
more...
MISC (140):
more...
Books (1):
  • RETチロシンキナーゼの生理機能
    ニューサイエンス社 2008
Works (9):
  • 扁平上皮癌特異的高発現を示す蛋白CD109の腫瘍マーカーとしての有用性の検討
    2009 - 2009
  • 癌・精巣抗原CD109の肺扁平上皮癌発生によける役割の解明と血清診断・分子標的癌治療への応用
    2009 -
  • DNA損傷応答に関わる蛋白REV7の細胞増殖・運動と個体発生における重要性の検討
    2007 - 2008
  • RETチロシンキナーゼの下流シグナルを調節する因子の探索と発癌制御への応用
    2008 -
  • 生活環境における吸入気体組成の調節に基づく健康維持と疾患制御の試み
    2008 -
more...
Education (4):
  • - 1995 Nagoya University
  • - 1995 Nagoya University Graduate School, Division of Medicine Depertment of Pathology
  • - 1988 Nara Medical University
  • - 1988 Nara Medical University Devision of Medicine
Professional career (1):
  • Doctor of Medicine (Nagoya University)
Work history (9):
  • 2006 - 2012 - 名古屋大学大学院医学系研究科病理病態学講座准教授
  • 2002 - 2006 名古屋大学大学院医学系研究科病理病態学講座講師
  • 2000 - 2002 名古屋大学大学院医学系研究科病理病態学講座助手
  • 2000 - 2002 Assistant Professor, Department of Pathology, Nagoya University Graduate School of Medicine
  • 1995 - 1996 名古屋記念病院腫瘍科医師
Show all
Committee career (1):
  • 2001 - 日本病理学会 評議員
Association Membership(s) (8):
日本臨床細胞学会 ,  日本病理学会 ,  日本癌学会 ,  アメリカ癌学会 ,  Japanese Society of Clinical Cytology ,  Japanese Sociaty of Pathology ,  Japanese Cancer Association ,  American Association for Cancer Research
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page